The Evaluate Renal Artery Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation (ERADICATE-AF) trial: arrhythmia suppression, blood pressure control, and potential interactions.
Jonathan S SteinbergNicholas BlountDmitry PonomarevVitaly ShabanovEvgeny PokushalovAlexander RomanovPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
Keyphrases
- catheter ablation
- atrial fibrillation
- blood pressure
- left atrial
- left atrial appendage
- oral anticoagulants
- phase iii
- direct oral anticoagulants
- study protocol
- heart failure
- clinical trial
- hypertensive patients
- percutaneous coronary intervention
- heart rate
- phase ii
- randomized controlled trial
- human health
- type diabetes
- open label
- coronary artery disease
- adipose tissue
- climate change
- left ventricular
- mitral valve
- weight loss
- blood glucose
- acute coronary syndrome